Clinical Trials Directory

Trials / Completed

CompletedNCT06349551

Clot Formation and Coagulation Factors Consumption in the Clearing Fluid After Arterial Catheter Blood Sampling.

Clot Formation and Coagulation Factors Consumption Over Time in the Clearing Fluid After Arterial Catheter Blood Sampling in Critically Ill Adult Patients. Prospective Observational Study.

Status
Completed
Phase
Study type
Observational
Enrollment
213 (actual)
Sponsor
Nantes University Hospital · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

After blood sampling from an arterial catheter, the reinjection of the clearing fluid (a mixture of saline solution and blood) is proposed to limit blood loss. However, the status of coagulation in this clearing liquid remains poorly documented.

Detailed description

In the intensive care unit, blood sampling is mainly performed through an arterial catheter (radial or femoral artery). In addition to continuous arterial pressure monitoring, this provides an easy access to arterial blood without the need for venipuncture. It is standard practice to first clear the arterial sampling line before drawing blood for biological tests, to prevent the blood sample from being diluted by the arterial catheter's perfusion solution. This clearing fluid (i.e., a mixture of saline solution and blood) is usually discarded. It has been reported that the clearing fluid volume alone represents 24 to 30% of the total blood volume required for blood sampling. Devices for reinjecting this clearing fluid are already on the market. The advantages of these devices include blood saving, reduced risk of blood exposure, reduced biological waste and lower infection rates associated with catheter handling. The main drawback of these devices is their cost and the need for frequent replacement. Moreover, their impact on the decrease of blood transfusion remains unclear. Furthermore, there are too few published data on the potential coagulation of clearing fluid reinjected into the patient nor the maximum time it can be safely reinjected. The aim of this study is to assess the activation of coagulation over time in the clearing fluid during arterial catheter blood sampling

Conditions

Interventions

TypeNameDescription
BIOLOGICALPatients of intensive care unitPatients of intensive care unit having an arterial catheter undergoing arterial blood sampling

Timeline

Start date
2024-04-16
Primary completion
2025-05-21
Completion
2025-05-21
First posted
2024-04-05
Last updated
2025-05-25

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06349551. Inclusion in this directory is not an endorsement.